These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1669137)

  • 21. Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism.
    Carter BL; Jones ME; Waickman LA
    Clin Pharm; 1985; 4(3):279-96. PubMed ID: 3891200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The treatment of deep venous thrombosis. Thrombolysis vs heparin].
    Schmutzler R
    Phlebologie; 1990; 43(4):656-65; discussion 666. PubMed ID: 2093922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermittent regional therapy with rt-PA is not superior to systemic thrombolysis in deep vein thrombosis (DVT)--a German multicenter trial.
    Schwieder G; Grimm W; Siemens HJ; Flor B; Hilden A; Gmelin E; Friedrich HJ; Wagner T
    Thromb Haemost; 1995 Nov; 74(5):1240-3. PubMed ID: 8607102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of heparin and streptokinase in the treatment of venous thrombosis.
    Porter JM; Seaman AJ; Common HH; Rösch J; Eidemiller LR; Calhoun AD
    Am Surg; 1975 Sep; 41(9):511-19. PubMed ID: 1101755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of thrombosis with conventional heparin].
    Harenberg J
    Z Kardiol; 1993; 82 Suppl 2():71-5. PubMed ID: 8328212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trial of China-made recombinant streptokinase in acute myocardial infarction. Collaborative Study Group on Thrombolysis with China-made recombinant streptokinase.
    Chin Med J (Engl); 1997 Jan; 110(1):50-2. PubMed ID: 9594322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT).
    Bratt G; Aberg W; Johansson M; Törnebohm E; Granqvist S; Lockner D
    Thromb Haemost; 1990 Dec; 64(4):506-10. PubMed ID: 1964751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fibrinolytic therapy in surgically treated intensive care patients].
    Harke H
    Klin Wochenschr; 1991; 69 Suppl 26():150-6. PubMed ID: 1813712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute myocardial infarction: thrombolytic efficacy of 500.000 UI of streptokinase combined with heparin].
    Aninat M; Col JJ; Rankin J; Jacquet L; Anwar A; Etienne J
    Rev Med Chil; 1990 Aug; 118(8):862-7. PubMed ID: 2152229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis.
    O'Meara JJ; McNutt RA; Evans AT; Moore SW; Downs SM
    N Engl J Med; 1994 Jun; 330(26):1864-9. PubMed ID: 8196729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic thrombin generation and activity resistant to low molecular weight heparin administered prior to streptokinase in patients with acute myocardial infarction.
    Nilsen DW; Gøransson L; Larsen AI; Hetland O; Kierulf P
    Thromb Haemost; 1997 Jan; 77(1):57-61. PubMed ID: 9031450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Systemic thrombolysis of arterial occlusions of the lower extremities. Comparison of various treatment schedules].
    Lämmle B; Noll G; Christe M; Fritschi J; Czendlik C; Marbet GA; Biland L; Da Silva A; Huber P; Widmer LK
    Schweiz Med Wochenschr; 1983 Oct; 113(43):1570-6. PubMed ID: 6227992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulation by constant subcutaneous heparin infusion.
    Parrilla N; Ansell J
    Thromb Haemost; 1982 Feb; 47(1):1-2. PubMed ID: 7071800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group.
    Charbonnier BA; Fiessinger JN; Banga JD; Wenzel E; d'Azemar P; Sagnard L
    Thromb Haemost; 1998 May; 79(5):897-901. PubMed ID: 9609216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Short-term lysis of venous thrombosis with ultra-high streptokinase doses].
    Anders O; Lakner V; Konrad H; Ernst B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):82-7. PubMed ID: 2427419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemostatic activation under anticoagulant treatment: a comparison of unfractionated heparin vs. nadroparin in the treatment of proximal deep vein thrombosis.
    Stricker H; Marchetti O; Haeberli A; Mombelli G
    Thromb Haemost; 1999 Oct; 82(4):1227-31. PubMed ID: 10544903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heparin in deep venous thrombosis of the leg--effectiveness and safety].
    Gatterer E; Stöllberger C; Slany J; Stöberl C; Jaksch J
    Wien Klin Wochenschr; 1988 Sep; 100(18):601-5. PubMed ID: 3188535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-coronary thrombolysis with streptokinase or lys-plasminogen/urokinase in acute myocardial infarction: effects on recanalization and blood fibrinolysis.
    de Prost D; Guerot C; Laffay N; Horellou MH; Samama M
    Thromb Haemost; 1983 Dec; 50(4):792-6. PubMed ID: 6665760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Report of experiences with fibrinolytic therapy of deep venous thrombosis of the legs].
    Schweder R; Ebert G; Rinke W; Ketterer KP
    Anaesthesiol Reanim; 1990; 15(2):81-5. PubMed ID: 2340058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.